Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 331 to 345 of 1284 results for social care

  1. Tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis [ID6351]

    In development Reference number: GID-TA11333 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Hepatitis B (QS65)

    This quality standard covers testing, diagnosing and managing hepatitis B in adults, young people and children (from birth). It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    28 July 2014
    View quality statements

    Sections for QS65

  3. Costing tool:- Which elements of health, social care or other support services work best at a local level and provide the best 'value for money' to address the needs of young people and adults with coexisting severe mental illness and substance misuse?

    NG58/3 Question Costing tool:- Which elements of health, social care or other support services work best at a local level and provide...

    Research recommendation
    Published
    10 February 2017

  4. Stage 5: discharge and transferring care

    Our guidance helps you hand over care and ensure people are safely transitioned out of the virtual ward environment.

  5. Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]

    In development Reference number: GID-TA11995 Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Patient and public involvement policy

    Read NICE's patient and public involvement policy.

  7. Patient and public involvement policy

    Read NICE's patient and public involvement policy.

  8. Renal cell carcinoma Pathways Pilot [ID6186]

    In development Reference number: GID-TA11186 Expected publication date: TBC

    Technology appraisal guidance
    In development

  9. Nogapendekin alfa inbakicept with intravesical BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG [ID6582]

    In development Reference number: GID-TA11767 Expected publication date:  04 November 2026

    Technology appraisal guidance
    In development

  10. Oesophago-gastric cancer (QS176)

    This quality standard covers assessing and managing oesophago-gastric cancer in adults. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    13 December 2018
    View quality statements

    Sections for QS176

  11. Dedicated key workers: What is the effectiveness of dedicated key workers for delivering joined-up services to meet the education, health and social care needs of disabled children and young people with severe complex needs?

    workers for delivering joined-up services to meet the education, health and social care needs of disabled children and young people with...

    Research recommendation
    Published
    8 April 2022

  12. Environmental adaptations: What are the most effective environmental adaptations to ensure the suitability and accessibility of the settings where disabled children and young people with severe complex needs receive education, health and social care support?

    young people with severe complex needs receive education, health and social care support? Any explanatory notes(if applicable) For a...

    Research recommendation
    Published
    8 April 2022

  13. History of NICE

    (QOF). 2010 First quality standard QS1 Dementia: support in health and social care (March). Read more about quality standards . First...

  14. Structure of NICE

    share the same mission: helping practitioners and commissioners get the best care to patients fast, while ensuring value for the...

  15. How we develop NICE guidelines

    The guidance development timeline